That doesn't suggest they are not thinking about it. Many breakthrough therapy designations have been granted for psilocybin during the treatment of resistant depression—that may be, depression that does not reply to a minimum of two different types of antidepressants—as well as a broader acceptance might be to the horizon.3rd Wave’s mission